Davion Johnson, CRA, LSSGB
Dir, Finance and Operations
Pathology Advanced Translational Research Unit
Department of Pathology & Laboratory Medicine
Davion has nearly 8 years of experience in research financial management and operations, primarily at Emory University. He has consistently demonstrated a commitment to excellence, earning recognition such as the ‘Rising Star’ award in 2017. Davion has managed various research administration functions and led process improvement projects, contributing to the development and implementation of effective solutions.
He holds a BA in Liberal Studies with a focus in Economics and Sociology, and a Minor in Business Administration from the University of South Carolina. Davion is a Certified Research Administrator, Lean Six Sigma Green Belt, and a 2021 graduate of Emory’s “Aspiring Leaders” program. He is currently pursuing a Master of Business Administration in Healthcare Management.
Rebeka Bordi MD, PhD, CRSP
Associate Director, Research Projects
Pathology Advanced Translational Research Unit
Department of Pathology & Laboratory Medicine
Dr. Bordi holds a Medical Degree from the University of Tirana, together with a Graduate Degree (PhD) in immunology. She received her Master’s in Clinical Research from Case Western Reserve University. She completed her medical residency in microbiology and infectious diseases at the Mother Tereza Hospital in Tirana and received post-doctoral training in immunology at National Institute for Public Health, Netherland. Dr. Bordi has practiced for twelve years in Albania as an MD and served as the Deputy Director of Institute of Public Health in Tirana before she came to North America.
Later, she has been engaged in HIV/AIDS research, collaborating in investigation of the impact of HV infection on thymic output. She has been leading projects, programs conducting seminal systems-level investigations to identify T cells mechanisms developing novel topical strategies to prevent HIV acquisition and investigating the pathogenesis of immune activation and inflammation in HIV infection. Using her extensive experience gained over years on cellular and clinical immunology, design of studies, setting up and monitoring of clinical, she coordinated different clinical trials focused on research and development of new therapies for immune modulation. These GLP/GCLP-compliant, multi-centric, placebo-controlled immune monitoring studies were conducted in a highly regulated environment. Dr. Bordi previously held the position of Clinical and Program Manager at Case Western University and Clinical Coordinator of Vaccine & Gene Therapy Institute of Florida Corp.
RESEARCH INTERESTS
Research activity includes projects in infectious diseases, specifically in HIV/AIDS research, oncology and vaccine development. She is currently focused on HIV in the context of drug abuse and cell gene therapy.